Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion type Assertion NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_head.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion wasGeneratedBy ECO_0000203 NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_provenance.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion wasDerivedFrom gad-20130706 NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_provenance.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion SIO_000772 16317430 NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_provenance.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion evidence source_evidence_literature NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_provenance.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_provenance.